Cargando…

Does Structured Exercise Improve Cognitive Impairment in People with Mild to Moderate Dementia? A Cost-Effectiveness Analysis from a Confirmatory Randomised Controlled Trial: The Dementia and Physical Activity (DAPA) Trial

BACKGROUND: Previous studies suggest that physical exercise could slow dementia progression. However, evidence for the cost effectiveness of structured exercise is conflicting and based on small trials. OBJECTIVES: The objective of this study was to compare the cost effectiveness of a tailored, stru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Iftekhar, Petrou, Stavros, Khan, Kamran, Mistry, Dipesh, Lall, Ranjit, Sheehan, Bart, Lamb, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533370/ https://www.ncbi.nlm.nih.gov/pubmed/30206826 http://dx.doi.org/10.1007/s41669-018-0097-9

Ejemplares similares

Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial
por: Lamb, Sarah E, et al.
Publicado: (2018)

Dementia and Physical Activity (DAPA) - an exercise intervention to improve cognition in people with mild to moderate dementia: study protocol for a randomized controlled trial
por: Atherton, Nicky, et al.
Publicado: (2016)

Is Protocolised Weaning that Includes Early Extubation Onto Non-Invasive Ventilation More Cost Effective Than Protocolised Weaning Without Non-Invasive Ventilation? Findings from the Breathe Study
por: Khan, Iftekhar, et al.
Publicado: (2020)

The DAPA Trial in the Context of Previous Prophylactic ICD Landmark Trials
por: Haanschoten, Danielle, et al.
Publicado: (2021)

Life review and life story books for people with mild to moderate dementia: a randomised controlled trial
por: Subramaniam, Ponnusamy, et al.
Publicado: (2013)

Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial
por: Ikeda, Manabu, et al.
Publicado: (2015)

DAPA-HF trial signals the birth of ‘diabetic cardiology’ and more
por: Wagdy, Kerolos, et al.
Publicado: (2020)

Musical dual-task training in patients with mild-to-moderate dementia: a randomized controlled trial
por: Chen, Yu-Ling, et al.
Publicado: (2018)

Randomised controlled trial of exercise to prevent shoulder problems in women undergoing breast cancer treatment: study protocol for the prevention of shoulder problems trial (UK PROSPER)
por: Bruce, Julie, et al.
Publicado: (2018)

Efficacy and safety of Tianmabianchunzhigan in mild to moderate vascular dementia: Protocol of a randomized controlled IIa trial
por: Tian, Jinzhou, et al.
Publicado: (2018)

Goal Setting for Cognitive Rehabilitation in Mild to Moderate Parkinson's Disease Dementia and Dementia with Lewy Bodies
por: Watermeyer, Tamlyn J., et al.
Publicado: (2016)

Cognitive Stimulation Therapy as an Adjunctive Treatment for Mild to Moderate Dementia
por: Kumar, S. Sandeep, et al.
Publicado: (2023)

Magnetic resonance imaging measures of brain volumes across the EXPEDITION trials in mild and moderate Alzheimer's disease dementia
por: Svaldi, Diana Otero, et al.
Publicado: (2022)

The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
por: McMurray, John J V, et al.
Publicado: (2020)

Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis
por: McEwan, Phil, et al.
Publicado: (2022)

Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia
por: Hannestad, Jonas, et al.
Publicado: (2020)

Unmet Needs and Behavioral Expressions: The Perspective of Individuals with Mild to Moderate Dementia
por: Minyo, Morgan, et al.
Publicado: (2020)

Moderators of Dual Task Gait Effects in Mild Cognitive Impairment and Dementia
por: Ofori, Edward, et al.
Publicado: (2021)

A phase 2 randomized, controlled trial of the α7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia
por: Gault, Laura M., et al.
Publicado: (2015)

Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations
por: Webster, Lucy, et al.
Publicado: (2017)

Outcomes measures in a decade of dementia and mild cognitive impairment trials
por: Harrison, Jennifer Kirsty, et al.
Publicado: (2016)

Latest Trends in Outcome Measures in Dementia and Mild Cognitive Impairment Trials
por: Garg, Divyani, et al.
Publicado: (2022)

The social functioning in dementia scale (SF-DEM): Exploratory factor analysis and psychometric properties in mild, moderate, and severe dementia
por: Budgett, Jessica, et al.
Publicado: (2019)

Dementia trials and dementia tribulations: methodological and analytical challenges in dementia research
por: Ritchie, Craig W, et al.
Publicado: (2015)

Combining cognitive stimulation therapy and fall prevention exercise (CogEx) in older adults with mild to moderate dementia: a feasibility randomised controlled trial
por: Binns, Elizabeth, et al.
Publicado: (2020)

Physical Performance and Quality of Life of Nursing-Home Residents with Mild and Moderate Dementia
por: Telenius, Elisabeth Wiken, et al.
Publicado: (2013)

Persistence and Prognostic Implications of Orthostatic Hypotension in Older Individuals with Mild-to-Moderate Dementia
por: Soennesyn, Hogne, et al.
Publicado: (2014)

Resilience in caregivers of people with mild-to-moderate dementia: findings from the IDEAL cohort
por: Martyr, Anthony, et al.
Publicado: (2023)

Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials
por: Ayati, Zahra, et al.
Publicado: (2020)

Comparison of Verbal and Emotional Responses of Elderly People with Mild/Moderate Dementia and Those with Severe Dementia in Responses to Seal Robot, PARO
por: Takayanagi, Kazue, et al.
Publicado: (2014)

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics
por: Wheeler, David C, et al.
Publicado: (2020)

Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial
por: Marx, Nikolaus, et al.
Publicado: (2021)

Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA‐CKD Trial
por: Chertow, Glenn M., et al.
Publicado: (2023)

A secondary analysis of a randomised controlled trial to investigate the effect of Tai Chi on the instrumented timed up and go test in people with mild to moderate dementia
por: Williams, Jonathan, et al.
Publicado: (2020)

A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial
por: Brown, Alexander J M, et al.
Publicado: (2020)

Virtual Reality-Based Cognitive Stimulation on People with Mild to Moderate Dementia due to Alzheimer’s Disease: A Pilot Randomized Controlled Trial
por: Oliveira, Jorge, et al.
Publicado: (2021)

A Nationwide Survey of Mild Cognitive Impairment and Dementia, Including Very Mild Dementia, in Taiwan
por: Sun, Yu, et al.
Publicado: (2014)

Promoting Activity, Independence, and Stability in Early Dementia and mild cognitive impairment (PrAISED): randomised controlled trial
por: Harwood, Rowan H, et al.
Publicado: (2023)

Can theory of mind deficits be measured reliably in people with mild and moderate Alzheimer’s dementia?
por: Choong, Caroline SM, et al.
Publicado: (2013)

Efficacy of Galantamine on Cognition in Mild-to-Moderate Alzheimer's Dementia after Failure to Respond to Donepezil
por: Hwang, Tae-Young, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_heucqug3irr9imufbu6sbil8sc